Glaucoma

Front Cover
Franz Grehn, Robert Stamper
Springer Science & Business Media, Oct 5, 2006 - Medical - 194 pages
Te series Essentials in Ophthalmology was initi- to discuss clinically relevant and appropriate t- ated two years ago to expedite the timely trans- ics. Summaries of clinically relevant information fer of new information in vision science and have been provided throughout each chapter. evidence-based medicine into clinical practice. Each subspecialty area now has been covered We thought that this prospicient idea would be once, and the response to the frst eight volumes moved and guided by a resolute commitment in the series has been enthusiastically positive. to excellence. It is reasonable to now update our With the start of the second cycle of subspecialty readers with what has been achieved. coverage, the dissemination of practical informa- Te immediate goal was to transfer informa- tion will be continued as we learn more about tion through a high quality quarterly publication the emerging advances in various ophthalmic in which ophthalmology would be represented by subspecialties that can be applied to obtain the eight subspecialties. In this regard, each issue has best possible care of our patients. Moreover, we had a subspecialty theme and has been overseen will continue to highlight clinically relevant - by two internationally recognized volume edi- formation and maintain our commitment to - tors, who in turn have invited a bevy of experts cellence. G. K. Krieglstein R. N.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

64 Barriers to Adherence and Persistence
99
641 Patient Demographics
100
643 Treatment Regimen Characteristics
101
651 Improve Motivation and Knowledge by Reinforcing the Importance of Adherence and Persistence
102
658 Consider Health System Issues
103
Epidemiology and Related Fields
106
Glaucoma Care in Developing Countries of Asia
107
71 The Problem
110

151 Clinical Evidence of Pulsatile Aqueous Flow
13
Short Term
14
162 Clinical Evidence of PumpDependent Pressure Regulation
15
Long Term
16
172 Trabecular Tissue Tethers and Signaling Mechanisms
17
174 Regulation of Trabecular Tissue Composition Is Pump Regulation
18
18 The Pump Fails to Control Pressure in Glaucoma
19
Pump Failure Mechanisms in Enucleated Eyes
22
19 Clinical Evidence of Pump Failure Mechanisms in Glaucoma
28
193 Pulsatile Aqueous Flow Stops with Episcleral Venous Pressure Increases
29
110 Conclusion
32
Risk Calculators EvidenceBased Care of Ocular Hypertension and Glaucoma Patients
35
21 Introduction
36
The Ocular Hypertension Treatment Study
37
225 Integrating Information from Studies
38
24 Implementing Information from Clinical Studies into Clinical Care of Patients
40
243 Benefits to Patients
41
244 Benefits to Society of a Risk Calculator
42
246 Future Risk Calculators
43
247 Conclusion
44
Dynamic Contour Tonometry
47
312 Principles and Problems of IOP Measurement Methods
48
313 Comparison of Common Tonometers
49
32 Dynamic Contour Tonometry
50
322 Measurement Procedure
51
323 Absolute and Relative Accuracy
53
33 Clinical Application of Dynamic Contour Tonometry
56
Experiences Advantages and Disadvantages
58
References
61
Effects of Corneal Thickness on Applanation Tonometry Pneumotonometry and Tonopen Measurements
64
43 Results of a Clinical Study
67
44 Pitfalls and Solutions for Tonometric Measurements
69
45 Conclusion
70
References
71
Electrophysiology in the Diagnosis of Glaucoma
73
512 The Importance of Early Detection of Glaucoma
74
Procedures in Ophthalmology
75
52 Early Detection of Glaucoma Using PERG Recordings
76
522 Neural Origin of PERG Responses
77
523 PERG Changes in Glaucoma
78
524 The Freiburg PERG Paradigm
81
53 VEP Recordings in Glaucoma
83
532 Multifocal VEP Recordings in Glaucoma
85
References
86
Adherence and Persistence in Glaucoma
91
62 Adherence
92
63 Persistence
96
732 Incidence of Primary Angle Closure
112
734 Risk Factors
113
74 Impact of Glaucoma on Patients and Access to Care
114
76 Laser Treatment
115
77 Surgery
116
78 Political Considerations
117
710 Conclusion
118
References
119
Health Economics CostEffectiveness and Glaucoma Care
123
812 Role of MicroEconomic Evaluation
125
822 Guidelines for Economic Evaluation
127
83 Economic Evaluation and Glaucoma Care
128
831 CostEffectiveness Analyses of Screening for Glaucoma
129
833 Other Cost Studies in Glaucoma
130
842 What Kind of Information Do We Need About Glaucoma Care?
131
References
132
Therapy Surgery
134
Future of IOPLowering Medication for Glaucoma Therapy
135
91 Introduction
138
922 Uveoscleral Outflow
146
93 Inflow Suppression
148
931 Basic Structure
149
933 Cannabinoids
150
942 Contact Lenses
151
943 Penetration Enhancers
152
95 IOP Monitoring
153
Filtering Bleb Imaging with Confocal Laser Technology Rostock Cornea Module
157
102 Confocal in Vivo FB Microscopy with RCMHRT II Based on the LaserScanning Technique
158
103 Biomicroscopic FB Analysis
160
104 General Anatomical Considerations
161
105 FB Confocal In Vivo LaserScanning Microscopy
163
1051 Normal Anatomy of the FB Relevant Region
164
1052 Filtering Blebs
165
1053 Clinical Relevance of Confocal In Vivo LaserScanning Microscopy in Filtering Bleb Evaluation
168
Miscellaneous
170
Update on TubeShunt Procedures for Glaucoma
173
1113 Therapeutic Options Related to Bleb Physiology
174
112 Indications for Implant Use
175
113 Surgical Techniques for TubeShunt Implantation
177
114 The Cornea and Glaucoma Implants
179
1143 Summarized Information from Publications Regarding Success of Glaucoma Implants and Penetrating Keratoplasty
180
116 Complications of Glaucoma Implants
181
1163 Motility Problems
182
117 New Glaucoma Implants
183
Subject Index
186
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information